Related references
Note: Only part of the references are listed.Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria
Sumei Zeng et al.
MALARIA JOURNAL (2022)
Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy
Matthew M. Ippolito et al.
CURRENT EPIDEMIOLOGY REPORTS (2021)
Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites
Ho Ning Wong et al.
FRONTIERS IN CHEMISTRY (2020)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives
Lloyd Tanner et al.
FRONTIERS IN PHARMACOLOGY (2019)
Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages
Dina Coertzen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate
Cornel Burger et al.
PHARMACEUTICAL RESEARCH (2018)
Accessible and distinct decoquinate derivatives active against Mycobacterium tuberculosis and apicomplexan parasites
Richard M. Beteck et al.
COMMUNICATIONS CHEMISTRY (2018)
The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites
Katharina Ehrhardt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities
Richard M. Beteck et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
ELQ-300 Prodrugs for Enhanced Delivery and Single-Dose Cure of Malaria
Galen P. Miley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice
Hongxing Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models
Sarah Schleiferboeck et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
Filipa P. da Cruz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
The history of decoquinate in the control of coccidial infections in ruminants
M. A. Taylor et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2012)
A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor
Tae-gyu Nam et al.
ACS CHEMICAL BIOLOGY (2011)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Synthesis and evaluation of carbamate prodrugs of a phenolic compound
Yasushi Igarashi et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins
M Akoachere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Development and application of high throughput plasma stability assay for drug discovery
L Di et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Utility of hepatocytes in predicting drug metabolism: Comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro
Y Naritomi et al.
DRUG METABOLISM AND DISPOSITION (2003)
Share Paper
